Gene · 337
Papers3,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study. | Lipids Health Dis | 2023 | 36978188 | PubTator, text mining | PubMed |
| The role of long non-coding RNAs in carbohydrate and fat metabolism in the liver. | Noncoding RNA Res | 2023 | 36970373 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals underlying host responses in pediatric respiratory syncytial virus pneumonia. | iScience | 2023 | 36968072 | PubTator, text mining | PubMed |
| The abundances of LTF and SOD2 in amniotic fluid are potential biomarkers of gestational age and preterm birth. | Sci Rep | 2023 | 36966172 | PubTator, text mining | PubMed |
| APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts. | J Am Acad Dermatol | 2023 | 36963506 | PubTator, text mining | PubMed |
| Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis. | Eur Heart J | 2023 | 36946431 | PubTator, text mining | PubMed |
| A primary cell-based in vitro model of the human small intestine reveals host olfactomedin 4 induction in response to Salmonella Typhimurium infection. | Gut Microbes | 2023 | 36939013 | PubTator, text mining | PubMed |
| Machine Learning-Based Urine Peptidome Analysis to Predict and Understand Mechanisms of Progression to Kidney Failure. | Kidney Int Rep | 2023 | 36938091 | PubTator, text mining | PubMed |
| Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial. | Res Pract Thromb Haemost | 2023 | 36923709 | PubTator, text mining | PubMed |
| miRNA-205: a future therapeutic molecule for liver diseases. | Future Drug Discov | 2023 | 36908931 | PubTator, text mining | PubMed |
| Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study. | Int J Mol Sci | 2023 | 36902035 | PubTator, text mining | PubMed |
| Lipids at the Nexus between Cerebrovascular Disease and Vascular Dementia: The Impact of HDL-Cholesterol and Ceramides. | Int J Mol Sci | 2023 | 36901834 | PubTator, text mining | PubMed |
| Multifaceted Transcriptional Network of Estrogen-Related Receptor Alpha in Health and Disease. | Int J Mol Sci | 2023 | 36901694 | PubTator, text mining | PubMed |
| Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer. | Cancers (Basel) | 2023 | 36900401 | PubTator, text mining | PubMed |
| Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case-control study. | Diabetol Metab Syndr | 2023 | 36899434 | PubTator, text mining | PubMed |
| Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics. | BMC Nephrol | 2023 | 36894904 | PubTator, text mining | PubMed |
| Metal-Organic Frameworks as Sensors for Human Amyloid Diseases. | ACS Sens | 2023 | 36892002 | PubTator, text mining | PubMed |
| Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. | Nat Med | 2023 | 36879129 | PubTator, text mining | PubMed |
Unveiling the therapeutic potential of cabozantinib-loaded poly D,L-lactic-co-glycolic acid and polysarcosine nanoparticles in inducing apoptosis and cytotoxicity in human HepG2 hepatocellular carcinoma cell lines and in vivo anti-tumor activity in SCID female mice. | Front Oncol | 2023 | 36874145 | PubTator, text mining | PubMed |
| Identification of Ameloblastin as an Amyloid Precursor Protein of Amyloid-Producing Ameloblastoma in Dogs and Cats. | Vet Sci | 2023 | 36851470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/337/papers?page=18